169 related articles for article (PubMed ID: 30075864)
1. A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study).
Meattini I; Pasinetti N; Meduri B; De Rose F; De Santis MC; Franco P; Lancellotta V; Rossi F; Saieva C; Desideri I; Delli Paoli C; D'Angelo E; Triggiani L; Bastiani P; Alongi F; Lozza L; Aristei C; Ricardi U; Scorsetti M; Livi L;
Radiother Oncol; 2019 Feb; 131():208-214. PubMed ID: 30075864
[TBL] [Abstract][Full Text] [Related]
2. Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series.
Meattini I; Saieva C; Bastiani P; Martella F; Francolini G; Lo Russo M; Paoletti L; Doria M; Desideri I; Terziani F; De Luca Cardillo C; Bendinelli B; Ciabatti C; Muntoni C; Tinacci G; Nori J; Smith H; Brancato B; Galli L; Sanchez LJ; Casella D; Bernini M; Orzalesi L; Carta GA; Bianchi S; Rossi F; Livi L
Breast; 2017 Jun; 33():139-144. PubMed ID: 28384565
[TBL] [Abstract][Full Text] [Related]
3. Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Donker M; Litière S; Werutsky G; Julien JP; Fentiman IS; Agresti R; Rouanet P; de Lara CT; Bartelink H; Duez N; Rutgers EJ; Bijker N
J Clin Oncol; 2013 Nov; 31(32):4054-9. PubMed ID: 24043739
[TBL] [Abstract][Full Text] [Related]
4. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
[TBL] [Abstract][Full Text] [Related]
5. Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery.
Rakovitch E; Sutradhar R; Lalani N; Nofech-Mozes S; Gu S; Goldberg M; Hanna W; Fong C; Paszat L
Breast Cancer Res Treat; 2019 Nov; 178(1):169-176. PubMed ID: 31325071
[TBL] [Abstract][Full Text] [Related]
6. Local Relapse After Breast-Conserving Therapy Versus Mastectomy for Extensive Pure Ductal Carcinoma In Situ ≥4 cm.
Hamilton SN; Nichol A; Wai E; Gondara L; Velásquez García HA; Speers C; Diocee R; Truong P
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):381-388. PubMed ID: 30253237
[TBL] [Abstract][Full Text] [Related]
7. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Baehner FL; Miller DP; Fong C; Gu S; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Slodkowska E; Anderson JM; Cherbavaz DB; Shak S; Paszat L
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053207
[TBL] [Abstract][Full Text] [Related]
8. Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study.
Nguyen TT; Hoskin TL; Day CN; Habermann EB; Goetz MP; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):2989-2998. PubMed ID: 28766214
[TBL] [Abstract][Full Text] [Related]
9. Including the Ductal Carcinoma-In-Situ (DCIS) Score in the Development of a Multivariable Prediction Model for Recurrence After Excision of DCIS.
Paszat L; Sutradhar R; Zhou L; Nofech-Mozes S; Rakovitch E
Clin Breast Cancer; 2019 Feb; 19(1):35-46. PubMed ID: 30190195
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
11. Ductal carcinoma in situ--the influence of the radiotherapy boost on local control.
Wong P; Lambert C; Agnihotram RV; David M; Duclos M; Freeman CR
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e153-8. PubMed ID: 21664063
[TBL] [Abstract][Full Text] [Related]
12. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
[TBL] [Abstract][Full Text] [Related]
13. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
[TBL] [Abstract][Full Text] [Related]
14. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age.
Miles RC; Gullerud RE; Lohse CM; Jakub JW; Degnim AC; Boughey JC
Ann Surg Oncol; 2012 Apr; 19(4):1153-9. PubMed ID: 21989658
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor-Negative Breast Cancer.
Daugherty EC; Daugherty MR; Bogart JA; Shapiro A
Clin Breast Cancer; 2016 Dec; 16(6):500-506.e2. PubMed ID: 27431462
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
Allred DC; Anderson SJ; Paik S; Wickerham DL; Nagtegaal ID; Swain SM; Mamounas EP; Julian TB; Geyer CE; Costantino JP; Land SR; Wolmark N
J Clin Oncol; 2012 Apr; 30(12):1268-73. PubMed ID: 22393101
[TBL] [Abstract][Full Text] [Related]
17. Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
van Hezewijk M; Bastiaannet E; Putter H; Scholten AN; Liefers GJ; Rea D; Hasenburg A; Paridaens R; Hozumi Y; Markopoulos C; Seynaeve C; Jones SE; Marijnen CA; van de Velde CJ
Radiother Oncol; 2013 Aug; 108(2):190-6. PubMed ID: 24044798
[TBL] [Abstract][Full Text] [Related]
18. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy.
Rakovitch E; Pignol JP; Hanna W; Narod S; Spayne J; Nofech-Mozes S; Chartier C; Paszat L
J Clin Oncol; 2007 Dec; 25(35):5591-6. PubMed ID: 17984188
[TBL] [Abstract][Full Text] [Related]
19. Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy.
Jiveliouk I; Corn B; Inbar M; Merimsky O
Oncology; 2009; 76(1):30-5. PubMed ID: 19033713
[TBL] [Abstract][Full Text] [Related]
20. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
